Evidence map›Paper›PMID 26249758›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2016

RNA Profiling in Human and Murine Transplanted Hearts: Identification and Validation of Therapeutic Targets for Acute Cardiac and Renal Allograft Rejection.

L N L Van Aelst, G Summer, S Li, S K Gupta, W Heggermont, K De Vusser, P Carai, M Naesens, J Van Cleemput, F Van de Werf and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Circulating T cell specific extracellular vesicle profiles in cardiac allograft acute cellular rejection.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  7. Review
  8. A gentler approach to monitor for heart transplant rejection.Frontiers in cardiovascular medicine · 2024
    Review
  9. The evolving use of biomarkers in heart transplantation: Consensus of an expert panel.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Review
  10. Liquid Biopsy, a Potential New Detection Method in Heart Allograft Rejection.Methods in molecular biology (Clifton, N.J.) · 2023
    Review
  11. MicroRNAs in kidney injury and disease.Nature reviews. Nephrology · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. IL-6 Directed Therapy in Transplantation.Current transplantation reports · 2021
    Review
  17. Review
  18. Article
  19. miR-149-5p Inhibits Vascular Smooth Muscle Cells Proliferation, Invasion, and Migration by Targeting Histone Deacetylase 4 (HDAC4).Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

L N L Van AelstDepartment of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
G SummerCenter for Heart Failure Research, Cardiovascular Research Institute Maastricht (CARIM), University Hospital Maastricht, Maastricht, the Netherlands.
S LiLaboratory of Experimental Transplantation, University of Leuven, Leuven, Belgium.
S K GuptaInstitute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.
W HeggermontDepartment of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
K De VusserDepartment of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.
P CaraiDepartment of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
M NaesensDepartment of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.
J Van CleemputDepartment of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
F Van de WerfDepartment of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
J VanhaeckeDepartment of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
T ThumInstitute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.
M WaerLaboratory of Experimental Transplantation, University of Leuven, Leuven, Belgium.
A-P PapageorgiouDepartment of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
B SchroenCenter for Heart Failure Research, Cardiovascular Research Institute Maastricht (CARIM), University Hospital Maastricht, Maastricht, the Netherlands.
S HeymansDepartment of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
KU Leuven · BEMaastricht University · NLMedizinische Hochschule Hannover · DENetherlands Heart Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute cellular rejection (ACR) is the adverse response of the recipient's immune system against the allogeneic graft. Using human surveillance endomyocardial biopsies (EMBs) manifesting ACR and murine allogeneic grafts, we profiled implicated microRNAs (miRs) and mRNAs. MiR profiling showed that miR-21, -142-3p, -142-5p, -146a, -146b, -155, -222, -223, and -494 increased during ACR in humans and mice, whereas miR-149-5p decreased. mRNA profiling revealed 70 common differentially regulated transcripts, all involved in immune signaling and immune-related diseases. Interestingly, 33 of 70 transcripts function downstream of IL-6 and its transcription factor spleen focus forming virus proviral integration oncogene (SPI1), an established target of miR-155, the most upregulated miR in human EMBs manifesting rejection. In a mouse model of cardiac transplantation, miR-155 absence and pharmacological inhibition attenuated ACR, demonstrating the causal involvement and therapeutic potential of miRs. Finally, we corroborated our miR signature in acute cellular renal allograft rejection, suggesting a nonorgan specific signature of acute rejection. We concluded that miR and mRNA profiling in human and murine ACR revealed the shared significant dysregulation of immune genes. Inflammatory miRs, for example miR-155, and transcripts, in particular those related to the IL-6 pathway, are promising therapeutic targets to prevent acute allograft rejection.

Indexed as

Gene Expression ProfilingAnimalsBiomarkersBlotting, WesternGraft RejectionHeart TransplantationHumansKidney TransplantationMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMicroRNAsReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionRNA, MessengerBiomarkersMicroRNAsMirn155 microRNA, mouseRNA, Messengerbasic (laboratory) research/scienceheart (allograft) function/dysfunctionheart transplantation/cardiologymicroarray/gene arraymolecular biology: micro RNAmolecular biology: mRNA/mRNA expressionrejection: acute

Identifiers

PMID26249758
PMCPMC5054886
OpenAlexW1954133876

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.